Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-065572
Filing Date
2025-07-03
Accepted
2025-07-03 08:01:18
Documents
1
Period of Report
2025-07-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2519819-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2519819-2_4seq1.xml 4 5551
  Complete submission text file 0001104659-25-065572.txt   7202
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Issuer) CIK: 0001279704 (see all company filings)

EIN.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RIB-X PHARMACEUTICALS, INC. 300 GEORGE STREET, SUITE 301 NEW HAVEN CT 06511
Business Address
Longcor Jarrod (Reporting) CIK: 0001545565 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36598 | Film No.: 251103784